$6.19
-0.06 (-0.96%)
Open$6.23
Previous Close$6.25
Day High$6.45
Day Low$6.10
52W High$8.05
52W Low$1.35
Volume—
Avg Volume251.6K
Market Cap106.40M
P/E Ratio3.57
EPS$2.29
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+351.4% upside
Current
$6.19
$6.19
Target
$27.94
$27.94
$24.18
$27.94 avg
$39.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 75.01M | 8.10M | 7.51M |
| Net Income | 41.63M | -2,253,266 | -2,377,750 |
| Profit Margin | 55.5% | -27.8% | -31.6% |
| EBITDA | 41.19M | -3,375,106 | -3,186,219 |
| Free Cash Flow | — | -1,035,116 | -1,228,536 |
| Rev Growth | +155.8% | +18.0% | -0.1% |
| Debt/Equity | 2.29 | 0.78 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |